Since 2021, I’ve worked as a process development engineer II in nucleic acid process sciences at Intellia in Cambridge, MA.

From 2019 to 2021, I worked in Pivotal Attribute Sciences at Amgen in Cambridge, MA.  I developed methods, performed analytical techniques and interpreted data for PD studies; here I gained experience in handling mAbs, bsAbs, fusion proteins, BiTEs, and oncolytic viruses.  Additionally, I developed and qualified analytical methods from the preclinical space, transferred new methods into QC and commercial sites, and drafted and reviewed protocols and technical reports.  I also developed a high throughput Pro-A purification process to clarify crude upstream samples for analytics.